Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage

V. K. Sharma, A. V. Sahai, F. A. Corder, Colin Howden

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Background: Helicobacter pylori eradication decreases ulcer recurrence and should prevent recurrent ulcer haemorrhage. Aim: By meta-analysis, to compare treatment of H. pylori infection with other approaches to prevent recurrent ulcer haemorrhage and, by cost minimization analysis, to determine the least costly strategy. Methods: We searched for randomized, controlled trials comparing treatment of H. pylori infection with ulcer healing alone or with maintenance therapy in preventing recurrent ulcer haemorrhage. We calculated the relative and absolute risk reductions and numbers needed to treat. Results: Treatment of H. pylori infection decreased recurrent bleeding by 17% (numbers needed to treat = 6) compared with ulcer healing treatment alone. Compared with ulcer healing treatment followed by maintenance therapy, recurrent bleeding was decreased by 4% (numbers needed to treat = 25). Decision model-based cost minimization analysis demonstrated that treatment of H. pylori infection was the least costly strategy unless the incidence of complicated recurrences after treatment was over 6%, or the cost of confirming eradication was over $741. Conclusions: Treatment of H. pylori infection is superior to ulcer healing treatment with or without maintenance therapy in preventing recurrent ulcer haemorrhage. All patients with ulcer bleeding should be tested for H. pylori infection and appropriately treated if positive.

Original languageEnglish (US)
Pages (from-to)1939-1947
Number of pages9
JournalAlimentary Pharmacology and Therapeutics
Volume15
Issue number12
DOIs
StatePublished - Dec 1 2001
Externally publishedYes

Fingerprint

Helicobacter pylori
Ulcer
Hemorrhage
Helicobacter Infections
Numbers Needed To Treat
Therapeutics
Costs and Cost Analysis
Recurrence
Meta-Analysis
Randomized Controlled Trials

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this

Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. / Sharma, V. K.; Sahai, A. V.; Corder, F. A.; Howden, Colin.

In: Alimentary Pharmacology and Therapeutics, Vol. 15, No. 12, 01.12.2001, p. 1939-1947.

Research output: Contribution to journalArticle

@article{a2c768703be140eb9414ac0f85ec8155,
title = "Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage",
abstract = "Background: Helicobacter pylori eradication decreases ulcer recurrence and should prevent recurrent ulcer haemorrhage. Aim: By meta-analysis, to compare treatment of H. pylori infection with other approaches to prevent recurrent ulcer haemorrhage and, by cost minimization analysis, to determine the least costly strategy. Methods: We searched for randomized, controlled trials comparing treatment of H. pylori infection with ulcer healing alone or with maintenance therapy in preventing recurrent ulcer haemorrhage. We calculated the relative and absolute risk reductions and numbers needed to treat. Results: Treatment of H. pylori infection decreased recurrent bleeding by 17{\%} (numbers needed to treat = 6) compared with ulcer healing treatment alone. Compared with ulcer healing treatment followed by maintenance therapy, recurrent bleeding was decreased by 4{\%} (numbers needed to treat = 25). Decision model-based cost minimization analysis demonstrated that treatment of H. pylori infection was the least costly strategy unless the incidence of complicated recurrences after treatment was over 6{\%}, or the cost of confirming eradication was over $741. Conclusions: Treatment of H. pylori infection is superior to ulcer healing treatment with or without maintenance therapy in preventing recurrent ulcer haemorrhage. All patients with ulcer bleeding should be tested for H. pylori infection and appropriately treated if positive.",
author = "Sharma, {V. K.} and Sahai, {A. V.} and Corder, {F. A.} and Colin Howden",
year = "2001",
month = "12",
day = "1",
doi = "10.1046/j.1365-2036.2001.01134.x",
language = "English (US)",
volume = "15",
pages = "1939--1947",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage

AU - Sharma, V. K.

AU - Sahai, A. V.

AU - Corder, F. A.

AU - Howden, Colin

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Background: Helicobacter pylori eradication decreases ulcer recurrence and should prevent recurrent ulcer haemorrhage. Aim: By meta-analysis, to compare treatment of H. pylori infection with other approaches to prevent recurrent ulcer haemorrhage and, by cost minimization analysis, to determine the least costly strategy. Methods: We searched for randomized, controlled trials comparing treatment of H. pylori infection with ulcer healing alone or with maintenance therapy in preventing recurrent ulcer haemorrhage. We calculated the relative and absolute risk reductions and numbers needed to treat. Results: Treatment of H. pylori infection decreased recurrent bleeding by 17% (numbers needed to treat = 6) compared with ulcer healing treatment alone. Compared with ulcer healing treatment followed by maintenance therapy, recurrent bleeding was decreased by 4% (numbers needed to treat = 25). Decision model-based cost minimization analysis demonstrated that treatment of H. pylori infection was the least costly strategy unless the incidence of complicated recurrences after treatment was over 6%, or the cost of confirming eradication was over $741. Conclusions: Treatment of H. pylori infection is superior to ulcer healing treatment with or without maintenance therapy in preventing recurrent ulcer haemorrhage. All patients with ulcer bleeding should be tested for H. pylori infection and appropriately treated if positive.

AB - Background: Helicobacter pylori eradication decreases ulcer recurrence and should prevent recurrent ulcer haemorrhage. Aim: By meta-analysis, to compare treatment of H. pylori infection with other approaches to prevent recurrent ulcer haemorrhage and, by cost minimization analysis, to determine the least costly strategy. Methods: We searched for randomized, controlled trials comparing treatment of H. pylori infection with ulcer healing alone or with maintenance therapy in preventing recurrent ulcer haemorrhage. We calculated the relative and absolute risk reductions and numbers needed to treat. Results: Treatment of H. pylori infection decreased recurrent bleeding by 17% (numbers needed to treat = 6) compared with ulcer healing treatment alone. Compared with ulcer healing treatment followed by maintenance therapy, recurrent bleeding was decreased by 4% (numbers needed to treat = 25). Decision model-based cost minimization analysis demonstrated that treatment of H. pylori infection was the least costly strategy unless the incidence of complicated recurrences after treatment was over 6%, or the cost of confirming eradication was over $741. Conclusions: Treatment of H. pylori infection is superior to ulcer healing treatment with or without maintenance therapy in preventing recurrent ulcer haemorrhage. All patients with ulcer bleeding should be tested for H. pylori infection and appropriately treated if positive.

UR - http://www.scopus.com/inward/record.url?scp=0035666303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035666303&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2036.2001.01134.x

DO - 10.1046/j.1365-2036.2001.01134.x

M3 - Article

VL - 15

SP - 1939

EP - 1947

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 12

ER -